by Dana-Farber Cancer Institute Graphical abstract. Credit: Cancer Cell (2022). DOI: 10.1016/j.ccell.2022.10.017 For many patients with a condition that often precedes multiple myeloma, early treatment can slow or delay the progression to myeloma. In a new study, investigators at Dana-Farber Cancer Institute demonstrate that changes in immune system cells can indicate which patients with high-risk “smoldering” myeloma...
